[Deficiency of 11beta-hydroxysteroid dehydrogenase type 2 (syndrome of apparent mineralocorticoid excess)].
Mune
Tomoatsu
T
Division of Endocrinology and Metabolism, Gifu University Graduate School of Medicine.
D043209:11-beta-Hydroxysteroid Dehydrogenase Type 2 / Q000235:genetics; D003937:Diagnosis, Differential; D000077545:Eplerenone; D043204:Mineralocorticoid Excess Syndrome, Apparent / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D000451:Mineralocorticoid Receptor Antagonists / Q000008:administration & dosage; D009154:Mutation; D011379:Prognosis; D013148:Spironolactone / Q000008:administration & dosage / Q000031:analogs & derivatives
D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone; D000077545:Eplerenone; D043209:11-beta-Hydroxysteroid Dehydrogenase Type 2